Highlights Allurion Technologies Inc.

Equities

ALUR

US02008G1022

Delayed Nyse Other stock markets 03:44:51 2024-05-21 pm EDT			5-day change	1st Jan Change
1.65 ^USD	-2.37%		-21.80%	-55.88%

May. 14	Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q1 Revenue $9.4M, vs. Street Est of $9M	MT
May. 14	Allurion Technologies Inc. Reiterates Revenue Guidance for the Year 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q1 Revenue $9.4M, vs. Street Est of $9M	May. 14	MT
Allurion Technologies Inc. Reiterates Revenue Guidance for the Year 2024	May. 14	CI
Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the First Quarter 2024	Apr. 30	CI
Sector Update: Health Care Stocks Slump Late Afternoon	Apr. 04	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	Apr. 04	MT
Sector Update: Health Care	Apr. 04	MT
Top Midday Gainers	Apr. 04	MT
Allurion Technologies' Shares, Trading Volume Jump After US Launch of Weight-Loss System	Apr. 04	MT
Allurion Technologies, Inc. Expands Virtual Care Suite to the United States	Apr. 04	CI
Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q4 Revenue $8.2M	Mar. 21	MT
Allurion Technologies Inc. Reiterates Earnings Guidance for the Full Year 2024	Mar. 21	CI
Allurion Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Allurion Technologies Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 21	CI
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss	Jan. 23	CI
Allurion Technologies, Inc.'s Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships	Jan. 17	CI
Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Full Year of 2023 and Full Year of 2024	Jan. 08	CI
Allurion Technologies Inc. Announces New Research Highlights the Positive Impact of GLP-1s and Other Anti-Obesity Medications on the Allurion Program	Jan. 05	CI
Allurion Technologies, Inc. Announces an Expanded Commercial Agreement with Weight Doctors	Jan. 02	CI
Earnings Flash (ALUR) ALLURION TECHNOLOGIES Posts Q3 Revenue $18.2M	Nov. 13	MT
Allurion Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Allurion Technologies Inc.

Equities

ALUR

US02008G1022

Highlights

Filters